Search:
» Overview
» Team
» Companies
» Initiatives
» Cleveland+
» Newsroom
Companies
>
Preclinical
NovelMed
’s platform technologies have led to the development of monoclonal antibodies and small molecule therapies for the treatment of arthritis, cardiovascular disease, stroke and cancer.
Funding:
Significant Grant Funding
Recent News
»
Minnesota, Ohio, Missouri Attract Most Midwest Health Care Investment
»
SPR Therapeutics Raises $2.2 Million
»
Philips Healthcare and Steris Announce Cleveland Expansions
»
Intelligent Mobile Support Receives Investment
»
ChanRx Raises Series A from Santé Ventures
Commercialized Products & Services
Syncro Blue Tube
One of the many health care innovations brought to market by client companies.
» View More
Exit Companies
Since 2002, 21 Cleveland-area health care companies have had successful exits.
» View More
Cleveland Medical Mart & Convention Center
The world’s only convention facility created for the health care industry.
» View More
Copyright © 2012 BioEnterprise |
Home
|
Disclaimer
|
Sitemap
|
Contact Us
BioEnterprise :
11000 Cedar Avenue, Cleveland, OH 44106 |
216.658.3999